Start the conversation
Biotechs continue to be hot.
If you own the right ones, that is ...
Shares of Inovio Pharmaceuticals Inc. (NYSE: INO), a synthetic-vaccine player we recommended back on Feb. 1, soared as much as 19% yesterday after the Blue Bell, Pa.-based biotech said that its universal H7N9 DNA Vaccine protected 100% of vaccinated animals in a challenge study.
This is premium content for Private Briefing subscribers only.